New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
06:10 EDTOCROmnicare upgraded to Buy from Neutral at UBS
UBS upgraded Omnicare due to valuation and said it now believes there is a large generic Namenda XR opportunity in 2016. Price target is $64.
News For OCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
10:24 EDTOCRHigh option volume stocks
High option volume stocks: TIVO TIF ASHR OCR TGP JEC CEQP UTX PWRD IMMU
08:31 EDTOCROmnicare, McKesson expand distribution agreement
Omnicare (OCR) and McKesson Corporation (MCK) announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. The new five year agreement, which extends through December 2019, creates efficiencies for both companies by leveraging the strength of Omnicare as the nationís largest institutional pharmacy and a leading specialty pharmaceutical services provider and McKesson as a global leader in pharmaceutical sourcing and supply chain management. Omnicare noted that it believes the benefits of its new sourcing strategy will be a key driver in enabling it to generate a low double-digit adjusted cash EPS growth rate in 2015.
November 11, 2014
10:20 EDTOCRHigh option volume stocks
High option volume stocks: RLGY TWC LITB SPM ACRX JWN OCR CALL CST ERIC

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use